West Pharmaceutical Services | WST - Nettoeinkommen

Aktienkurs
265.93
Täglich Wechseln
6.58 2.54%
Monatlich
7.20%
Jährlich
30.66%
Q2 Prognose
247.13




Nettoeinkommen Veränderung Datum
Align Technology USD 135.76M 79.01M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Cerus USD -20.92M 17.98M 2024-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Cooper Companies USD 130.8M 46.2M 2025-12
Dentsply International USD -146M 281M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
ICU Medical USD -15.73M 12.34M 2025-12
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
J&J USD 5.12B 36M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 27.76M 4.83M 2025-09
Neogen USD -15.92M 52.26M 2025-09
OraSure Technologies USD -19.29M 5.57M 2025-12
Quidel USD -733M 477.6M 2025-09
Repligen USD 13.29M 1.62M 2025-12
Rockwell Medical USD 343K 2.07M 2024-06
Solventum Corp USD 63M 1.2B 2025-12
STAAR Surgical USD -18.31M 27.19M 2025-12
Terumo JPY 32.65B 2.4B 2025-12
Utah Medical Products USD 2.57M 445K 2025-12
West Pharmaceutical Services USD 132.1M 7.9M 2025-12